Search Results - "Guiotto, C"

P.08.7 CLINICAL IMPLICATIONS AND STABILITY OF DETERMINATION OF INFLIXIMAB TROUGH LEVELS (IFX-TL) AND ANTIBODIES TO INFLIXIMAB (ATI) IN INFLAMMATORY BOWEL DISEASE by Daperno, M, Fracchia, M, Guiotto, C, Germano, L, Ercole, E, Rigazio, C, Lavagna, A, Migliardi, M, Pellerito, R, Rocca, R

Get full text

P.03.13 COMPARISON OF THE PERFORMANCE OF TWO COMMERCIALLY AVAILABLE TESTS FOR DETERMINATION OF INFLIXIMAB TROUGH LEVELS (IFX-TL) AND ANTIBODIES TO INFLIXIMAB (ATI), PROMONITOR AND IMMUNDIAGNOSTIK, IN INFLAMMATORY BOWEL DISEASE by Daperno, M, Frigerio, F, Guiotto, C, Laura, G, Ercole, E, Lavagna, A, Rigazio, C, Aricò, S, Migliardi, M, Pellerito, R, Rocca, R

Get full text

T.03.3 FECAL SMALL NON-CODING RNAS AND MICROBIOME CHARACTERIZE PATIENTS WITH CELIAC DISEASE by Francavilla, A., Ferrero, G., Pardini, B., Tarallo, S., Zanatto, L., Caviglia, G.P., Sieri, S., Grioni, S., Francescato, G., Stalla, F., Guiotto, C., Crocellà, L., Astegiano, M., Bruno, M., Vineis, P., Ribaldone, D.G., Naccarati, A.

Get full text

P.07.1 SWITCHING FROM INFLIXIMAB ORIGINATOR TO A FIRST BIO SIMILAR IS SAFE AND EFFECTIVE. A SINGLE CENTER SERIES WITH THROUGH LEVELS AND ANTI-DRUG ANTIBODIES DETERMINATION by Daperno, M., Guiotto, C., Italia, A., Lavagna, A., Negri, A., Ercole, E., Cosimato, M., Rigazio, C., Rocca, R.

Get full text

P588 Switching from infliximab originator to a first biosimilar is safe and effective: A single-centre series with through levels and anti-drug antibodies determination by Daperno, M, Guiotto, C, Italia, A, Lavagna, A, Negri, A, Ercole, E, Cosimato, M, Rigazio, C, Rocca, R

“…Abstract Background Treatment of inflammatory bowel disease (IBD) with anti-TNF drugs is hampered by notable costs. Over the past 2 years, CPT-13, a biosimilar…”
Get full text

P569 Clinical correlations of infliximab trough levels (IFX-TL) and antibodies to infliximab (ATI) in inflammatory bowel disease by Daperno, M., Lavagna, A., Fracchia, M., Guiotto, C., Germano, L., Rigazio, C., Ercole, E., Migliardi, M., Pellerito, R., Rocca, R.

Get full text

P508 Evaluation of the diagnostic performance of two commercially available tests for infliximab trough levels (IFX-TL) and antibodies to infliximab (ATI) titration in inflammatory bowel disease (IBD) by Daperno, M., Frigerio, F., Guiotto, C., Germano, L., Ercole, E., Aricò, S., Fracchia, M., Rigazio, C., Lavagna, A., Pellerito, R., Migliardi, M., Rocca, R.

Get full text

Pérdidas de fertilizantes nitrogenados, por volatilización, utilizando urea y fosfato díamóníco en dos sistemas de labranza by C. O. Guiotto, F. G. Rióla

“…Las pérdidas de nitrógeno por volatilización del amonio es una de las vías por las que se reduce la eficiencia en el uso de los fertilizantes nitrogenados en…”
Get full text